Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Intimin-Tir complex is a pivotal protein-protein interaction between the bacterial outer membrane protein Intimin and the Translocated intimin receptor (Tir) [1, 3]. This interaction is the defining feature of infections caused by attaching and effacing (A/E) pathogens, most notably Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic Escherichia coli (EHEC) [1, 11]. During the infection process, the bacterium utilizes a Type III Secretion System (T3SS) to translocate Tir into the host cell plasma membrane [2, 14]. Once integrated, Tir serves as a high-affinity receptor for Intimin, which is displayed on the bacterial surface [3, 11]. This binding event triggers a complex signaling cascade within the host cell, leading to the reorganization of the actin cytoskeleton and the formation of characteristic pedestal-like structures beneath the adherent bacteria [1, 8, 11]. Because the Intimin-Tir interaction is essential for stable colonization and subsequent pathogenesis, it represents a significant target for anti-virulence therapeutic strategies [7, 20]. Current research focuses on developing small molecule inhibitors, monoclonal antibodies, and peptides that can disrupt this interaction to prevent bacterial attachment and disease progression without the selective pressure of traditional antibiotics [19, 20, 21].
Inhibition of bacterial attachment to host cells and prevention of attaching and effacing (A/E) lesion formation [7, 20].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intimin-Translocated intimin receptor complex (Intimin-Tir).